This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
6ip9
From Proteopedia
(Difference between revisions)
m (Protected "6ip9" [edit=sysop:move=sysop]) |
|||
| (One intermediate revision not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Crystal Structure of Lanthanum ion (La3+) bound bovine alpha-lactalbumin== | |
| + | <StructureSection load='6ip9' size='340' side='right' caption='[[6ip9]], [[Resolution|resolution]] 1.85Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[6ip9]] is a 1 chain structure. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=5x84 5x84]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6IP9 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6IP9 FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=LA:LANTHANUM+(III)+ION'>LA</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6ip9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ip9 OCA], [http://pdbe.org/6ip9 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ip9 RCSB], [http://www.ebi.ac.uk/pdbsum/6ip9 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ip9 ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/LALBA_BOVIN LALBA_BOVIN]] Regulatory subunit of lactose synthase, changes the substrate specificity of galactosyltransferase in the mammary gland making glucose a good acceptor substrate for this enzyme. This enables LS to synthesize lactose, the major carbohydrate component of milk. In other tissues, galactosyltransferase transfers galactose onto the N-acetylglucosamine of the oligosaccharide chains in glycoproteins. | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Cancer remains one of the biggest threats to human society. There are massive demands for compounds to selectively kill cancerous cells. Earlier studies have shown that bovine alpha -lactalbumin made lethal to tumor cells (BAMLET) becomes cytotoxic against cancer cells in complex with oleic acid {Hoque, M. et. al., PLoSOne 8, e68390 (2013)}. In our study, we obtained bovine alpha-lactalbumin complexed with lanthanum ion (La(3+)-B-alpha-LA) and determined its high resolution crystal structure. The natural calcium binding site of bovine alpha-lactalbumin is replaced by lanthanum. The La(3+) complex formation by B-alpha-apo-LA was also supported by various biophysical methods. Interestingly, our complex, La(3+)-B-alpha-LA exhibits much greater anticancer activity against breast cancer cells as compared to the reported BAMLET-oleic acid complex. This study shows that La(3+)-B-alpha-LA complex is preferentially more toxic to MCF-7 cells as compared to KB (oral cancer) and HeLa (cervical) cells, while almost non-toxic to the healthy cells that we studied. Our data indicates that the cytotoxicity of La(3+)-B-alpha-LA against cancer cells is through apoptotic path way. The higher anticancer activity of La(3+)-B-alpha-LA is attributable to the requisite structural changes induced in the protein by La(3+) binding as supported by the crystal structure of the complex. | ||
| - | + | Cytotoxicity of apo bovine alpha-lactalbumin complexed with La(3+) on cancer cells supported by its high resolution crystal structure.,Yarramala DS, Prakash P, Ranade DS, Doshi S, Kulkarni PP, Bhaumik P, Rao CP Sci Rep. 2019 Feb 11;9(1):1780. doi: 10.1038/s41598-018-38024-1. PMID:30741951<ref>PMID:30741951</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | + | <div class="pdbe-citations 6ip9" style="background-color:#fffaf0;"></div> | |
| - | + | == References == | |
| - | + | <references/> | |
| + | __TOC__ | ||
| + | </StructureSection> | ||
[[Category: Bhaumik, P]] | [[Category: Bhaumik, P]] | ||
| + | [[Category: Prakash, P]] | ||
| + | [[Category: Rao, C P]] | ||
| + | [[Category: Yarramala, S D]] | ||
| + | [[Category: Bamlet]] | ||
| + | [[Category: Bovine alpha-lactalbumin]] | ||
| + | [[Category: Hamlet]] | ||
| + | [[Category: Lanthanum]] | ||
| + | [[Category: Metal binding protein]] | ||
Current revision
Crystal Structure of Lanthanum ion (La3+) bound bovine alpha-lactalbumin
| |||||||||||
